A new large-scale study paints a picture.
, the latest research from Israel suggests just how big of a difference a third dose can make—especially for young people. In the recent study, people 16 to 49 years old were 13 times less likely to test positive for COVID-19 after a booster shot of the Pfizer-BioNTech, even as coronavirus cases in the country surged. The strongest protection began two weeks after the third dose and continued until the study ended a few weeks later.
Of course, the omicron variant wasn’t a factor at the time the research was conducted. But there’s reason to be hopeful anyway.announced Wednesday that laboratory tests suggest a booster shot offers protection against the omicron variant. That was based on a study that took blood samples from people who had received two doses of the Pfizer vaccine and also looked at samples from people who received a booster dose one month prior.
But people who received a booster dose had 25 times the number of antibodies, and also increased the number of specific T-cells that should work against the omicron variant too. “Although two doses of the vaccine may still offer protection against severe disease caused by the omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said Albert Bourla, chairman and chief executive officer for Pfizer in a press release.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pfizer says its COVID-19 booster shot offers protection against the Omicron variantPfizer says a booster dose of its COVID-19 vaccine may protect against the new Omicron variant, which early indications show might be more contagious.
続きを読む »
Pfizer says booster dose of Covid vaccine appears to protect against omicron variant“Right now, the booster [is] looking really, really good against omicron,” Meg Tirrell says of Pfizer data showing its booster dose of Covid-19 vaccine appears to protect against the omicron variant.
続きを読む »
FDA authorizes Pfizer/BioNTech Covid-19 vaccine boosters for 16- and 17-year-oldsThe US Food and Drug Administration on Thursday authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in people ages 16 and 17. It's the first Covid-19 vaccine booster authorized for this age group in the United States.
続きを読む »
Paper certificates for Covid-19 booster jabs in JerseyA digital certificate was launched in Jersey in October, but was forced to shut hours after opening.
続きを読む »
10 Best Disposable Face Masks to Help Protect Against COVID-19Not only are these masks pretty much as sleek as a disposable one can get, they're made in an FDA-registered PPE factory and are shipped in sterile 100% plant-based, biodegradable packaging. But wait, there's more\u201410% of each mask sold goes to One Tree Planted.
続きを読む »